Acne Scars study: ELAPR002f Injectable Gel
Official title A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
ClinicalTrials.gov ID: NCT07207369
What this study is testing
- What it's testing
- The study aims to find out if the new gel is safe and if it helps improve the look of acne scars.
- Who it's for
- Adults with moderate to severe acne scars on both cheeks are being looked for.
- What's involved
- Participants will get three injections into the skin over two months. They will also have regular check-ups, blood tests, and fill out questionnaires.
- Time commitment
- The study lasts up to 14 months, including the initial treatment period and follow-up visits.
- Phase 3: a large, late-stage study
- Time commitment: about 2 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 22 and older
You may be able to join if
- Participants in general good health, and seeking improvement of atrophic acne scars.
- Moderate to severe atrophic acne scarring (Grade 4 or 5 on the Allergan Acne Scar Improvement Scale [ASIS]) on each cheek based on evaluating...
- At least 5 rolling or boxcar-type acne scars in total within the predefined 4 cm × 4 cm assessment field of either cheek in areas of otherwise normal...
You likely can't join if
- The participant has clinically significant acne on the face.
- Current cutaneous or mucosal inflammatory or infectious processes other than acne (eg, herpes), rosacea, abscess, an unhealed wound, or a cancerous...
- The participant presents with predominantly ice pick scars.
- History of keloid scar formation, hypertrophic scarring, and/or post inflammatory hyperpigmentation or hypopigmentation.
The study team makes the final eligibility decision.
Where it is enrolling
- Glendale, Arizona, United States
- Redondo Beach, California, United States
- Vista, California, United States
- Westport, Connecticut, United States
- Alpharetta, Georgia, United States
- Baltimore, Maryland, United States
- Mount Kisco, New York, United States
- Wilmington, North Carolina, United States
- Pflugerville, Texas, United States
- Arlington, Virginia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 2 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 22 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Glendale, Arizona, United States; Redondo Beach, California, United States; Vista, California, United States; Westport, Connecticut, United States; Alpharetta, Georgia, United States; Baltimore, Maryland, United States and 4 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.